Description
Alerdez (Dezloratadin) Syrup 0.5 mg/ml – 100 ml Vial
Composition
Active Ingredient: Dezloratadin 0.5 mg/ml
Mechanism of Action
Pharmacological Properties: Dezloratadin, a non-sedating antihistamine, acts by blocking histamine receptors in the body, thereby alleviating symptoms of allergic reactions like sneezing, itching, and rhinorrhea.
Indications for Use
Indications: Alerdez syrup is indicated for the management of symptoms related to allergic rhinitis and chronic idiopathic urticaria.
Contraindications
Contraindications: Alerdez syrup should not be used in individuals with a known hypersensitivity to dezloratadin or any components of the formulation.
Side Effects
Common side effects of Alerdez may include drowsiness. It is advised to refrain from activities like driving or operating heavy machinery until the effects of the medication are understood. Consult a healthcare provider before use, especially during pregnancy or breastfeeding.
Usage Instructions
Dosage: The recommended dose for adults and children over 12 years is 5 ml (equivalent to 2.5 mg dezloratadin) once daily. Shake well before use and utilize the provided measuring device for accurate dosing. Do not exceed the prescribed dosage.
Benefits Compared to Analogues
Alerdez has shown superior efficacy in managing allergic conditions compared to other antihistamines. Its rapid onset of action and sustained relief make it a preferred choice for allergic rhinitis and urticaria.
Suitable Patient Groups
Alerdez is suitable for adults and children over 12 years of age. It is important to adjust the dosage for pediatric patients based on their weight and age. Consult a healthcare professional for appropriate dosing in specific patient populations.
Storage and Shelf Life
Store Alerdez syrup at room temperature away from direct sunlight and moisture. Check the expiration date on the packaging and do not use the product beyond the stated shelf life.
Packaging Description
Alerdez syrup is available in a 100 ml vial with a concentration of 0.5 mg/ml dezloratadin. The packaging includes clear instructions for use and a measuring device for accurate dosing.
Clinical Evidence and Effectiveness
Studies have demonstrated the efficacy of dezloratadin in managing symptoms of allergic rhinitis and chronic idiopathic urticaria. Research published in reputable journals like the Journal of Allergy and Clinical Immunology and the Annals of Allergy, Asthma & Immunology have shown significant improvement in symptoms with the use of dezloratadin.
